AU767903B2 - Preparation of human papillomavirus E1 having helicase activity and method therefor - Google Patents

Preparation of human papillomavirus E1 having helicase activity and method therefor Download PDF

Info

Publication number
AU767903B2
AU767903B2 AU35923/99A AU3592399A AU767903B2 AU 767903 B2 AU767903 B2 AU 767903B2 AU 35923/99 A AU35923/99 A AU 35923/99A AU 3592399 A AU3592399 A AU 3592399A AU 767903 B2 AU767903 B2 AU 767903B2
Authority
AU
Australia
Prior art keywords
leu
ser
asp
thr
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU35923/99A
Other languages
English (en)
Other versions
AU3592399A (en
Inventor
Chris M. Farnet
Alex Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Canada Ltd
Original Assignee
Boehringer Ingelheim Canada Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Canada Ltd filed Critical Boehringer Ingelheim Canada Ltd
Publication of AU3592399A publication Critical patent/AU3592399A/en
Application granted granted Critical
Publication of AU767903B2 publication Critical patent/AU767903B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU35923/99A 1998-05-01 1999-04-28 Preparation of human papillomavirus E1 having helicase activity and method therefor Ceased AU767903B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8394298P 1998-05-01 1998-05-01
US60/083942 1998-05-01
PCT/CA1999/000389 WO1999057283A1 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus e1 having helicase activity and method therefor

Publications (2)

Publication Number Publication Date
AU3592399A AU3592399A (en) 1999-11-23
AU767903B2 true AU767903B2 (en) 2003-11-27

Family

ID=22181652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35923/99A Ceased AU767903B2 (en) 1998-05-01 1999-04-28 Preparation of human papillomavirus E1 having helicase activity and method therefor

Country Status (9)

Country Link
US (1) US6306580B1 (enExample)
EP (1) EP1073750A1 (enExample)
JP (1) JP2002513813A (enExample)
AU (1) AU767903B2 (enExample)
CA (1) CA2326402A1 (enExample)
HU (1) HUP0101396A3 (enExample)
IL (1) IL139270A0 (enExample)
NZ (1) NZ508519A (enExample)
WO (1) WO1999057283A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE387500T1 (de) * 1998-07-21 2008-03-15 Boehringer Ingelheim Ca Ltd Regionen des papillomavirus-e1-helikase beteiligt an e1 oligomerisierung
MXPA01012921A (es) 1999-06-17 2002-09-18 Boehringer Ingelheim Ltd Nuevo ensayo de atpasa.
GB0017990D0 (en) * 2000-07-21 2000-09-13 Glaxo Group Ltd Papilloma virus sequences
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
AU2003215244A1 (en) * 2002-02-14 2003-09-04 Curagen Corporation Complexes and methods of using same
USD1070308S1 (en) * 2023-07-13 2025-04-15 Wolverine Outdoors, Inc. Footwear sole
USD1067594S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole
USD1067593S1 (en) * 2023-07-13 2025-03-25 Wolverine Outdoors, Inc. Footwear sole

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011290A1 (en) * 1990-12-21 1992-07-09 Cetus Oncology Corporation Medicaments for the treatment of papillomavirus diseases

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992011290A1 (en) * 1990-12-21 1992-07-09 Cetus Oncology Corporation Medicaments for the treatment of papillomavirus diseases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MOHR I.J. ET AL., SCIENCE, 1990, 250: 1694-1699 *
YANG L. ET AL., PNAS 1993, 90(11): 5086-5090 *

Also Published As

Publication number Publication date
AU3592399A (en) 1999-11-23
HUP0101396A3 (en) 2006-03-28
CA2326402A1 (en) 1999-11-11
NZ508519A (en) 2003-12-19
IL139270A0 (en) 2001-11-25
WO1999057283A1 (en) 1999-11-11
EP1073750A1 (en) 2001-02-07
HUP0101396A2 (hu) 2001-08-28
US6306580B1 (en) 2001-10-23
JP2002513813A (ja) 2002-05-14

Similar Documents

Publication Publication Date Title
Hughes et al. E1 protein of human papillomavirus is a DNA helicase/ATPase
Gross et al. The nucleoside triphosphatase and helicase activities of vaccinia virus NPH-II are essential for virus replication
AU767903B2 (en) Preparation of human papillomavirus E1 having helicase activity and method therefor
EP1370682A2 (en) Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
Yang et al. Biochemical characterization of Periplaneta fuliginosa densovirus non-structural protein NS1
AU714821B2 (en) Methods, kits, and compositions for diagnosing papillomavirus infection
MÜLLER et al. Domains of the E1 protein of human papillomavirus type 33 involved in binding to the E2 protein
Poon et al. The phenotype in vitro and in infected cells of herpes simplex virus 1 alpha trans-inducing factor (VP16) carrying temperature-sensitive mutations introduced by substitution of cysteines
MXPA00010584A (en) Preparation of human papillomavirus e1 having helicase activity and method therefor
US6916622B2 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
AU2776792A (en) Methods and compositions for identifying inhibitors of papilloma virus replication
CN114560950A (zh) 一种遗传编码的有机汞荧光探针及其制备方法和应用
GB2311069A (en) Primase isolated from human cytomegalovirus (HCMV)
AU2004200590A1 (en) Regions of papilloma virus E1 helicase involved in E1 oligomerization
MXPA01000693A (en) Regions of papilloma virus e1 helicase involved in e1 oligomerization
WO1999057536A2 (en) Cyclin activation kinase (cak) from human pathogens, and uses related thereto
AU2002244566B2 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV
Larson et al. Functional Characterization of a Purified, Recombinant NF-κB/IκB Complex
JP2004173691A (ja) 変異型エストロゲンレセプターαおよびその遺伝子
JP2004173689A (ja) 変異型エストロゲンレセプターαおよびその遺伝子
JPH08304403A (ja) 抗クラミジア・ニューモニエ抗体の検出・測定方法及びその試薬、並びにクラミジア・ニューモニエ感染の診断薬
KR19990086165A (ko) Cdk４ 의 저해제인 p16의 카복시말단이 절단된 결손형cδp１６ 단백질, 그의 유전자
AU2002244566A1 (en) Assay for identifying inhibitors of the RNA dependent RNA polymerase (NS5B) of HCV

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)